TDG vs TVTX · P/E 41, rev $8.83B vs rev $296.8M
Transdigm Group Incorporated (TDG) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
TDG currently screens at market cap $73.65B and trailing P/E 41.1. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the TDG and TVTX stock pages for the full models.
Not investment advice.